- Home
- SMTC vs SRRK Comparison
SMTC vs SRRK Comparison
Compare SMTC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMTC | SRRK |
|---|---|---|
| Founded | 1960 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SMTC | SRRK |
|---|---|---|
| Price | $72.99 | $46.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 9 |
| Target Price | ★ $75.13 | $47.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.0M |
| Earning Date | 11-24-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $1,026,622,000.00 | N/A |
| Revenue This Year | $17.67 | N/A |
| Revenue Next Year | $13.46 | $20,271.77 |
| P/E Ratio | $218.25 | ★ N/A |
| Revenue Growth | ★ 20.60 | N/A |
| 52 Week Low | $24.05 | $22.71 |
| 52 Week High | $81.32 | $48.28 |
Technical Indicators
Market Signals| Indicator | SMTC | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 71.16 |
| Support Level | $71.21 | $43.92 |
| Resistance Level | $81.32 | $46.32 |
| Average True Range (ATR) | 4.50 | 2.12 |
| MACD | 0.35 | 0.14 |
| Stochastic Oscillator | 58.07 | 85.75 |
Price Performance
Historical ComparisonAbout SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.